open access

Vol 80, No 4 (2022)
Short communication
Published online: 2022-02-16
Get Citation

The use of remote monitoring of patients with cardiac implantable electronic devices in Poland

Mateusz Tajstra1, Maciej Dyrbuś1, Marcin Grabowski2, Jakub K Rokicki2, Marcin Nowak3, Mariusz Gąsior1
DOI: 10.33963/KP.a2022.0050
Pubmed: 35176170
Kardiol Pol 2022;80(4):479-481.
  1. 3rd Department of Cardiology, School of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
  2. 1st Chair and Department of Cardiology, Medical University of Warsaw, Warszawa, Poland
  3. Biotronik Polska, Poznań, Poland

open access

Vol 80, No 4 (2022)
Short communication
Published online: 2022-02-16


Not available


Not available
Get Citation
Supp./Additional Files (1)
Supplementary material
About this article

The use of remote monitoring of patients with cardiac implantable electronic devices in Poland


Kardiologia Polska (Polish Heart Journal)


Vol 80, No 4 (2022)

Article type

Short communication



Published online


Page views


Article views/downloads






Bibliographic record

Kardiol Pol 2022;80(4):479-481.


Mateusz Tajstra
Maciej Dyrbuś
Marcin Grabowski
Jakub K Rokicki
Marcin Nowak
Mariusz Gąsior

References (12)
  1. Kurek A, Tajstra M, Gadula-Gacek E, et al. Impact of Remote Monitoring on Long-Term Prognosis in Heart Failure Patients in a Real-World Cohort: Results From All-Comers COMMIT-HF Trial. J Cardiovasc Electrophysiol. 2017; 28(4): 425–431.
  2. Michowitz Y, Kronborg MB, Glikson M, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Europace. 2022; 24(1): 71–164.
  3. Hindricks G, Taborsky M, Glikson M, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet. 2014; 384(9943): 583–590.
  4. Hindricks G, Varma N, Kacet S, et al. Daily remote monitoring of implantable cardioverter-defibrillators: insights from the pooled patient-level data from three randomized controlled trials (IN-TIME, ECOST, TRUST). Eur Heart J. 2017; 38(22): 1749–1755.
  5. Tajstra M, Sokal A, Gadula-Gacek E, et al. Remote Supervision to Decrease Hospitalization Rate (RESULT) study in patients with implanted cardioverter-defibrillator. Europace. 2020; 22(5): 769–776.
  6. Wita M, Orszulak M, Szydło K, et al. The usefulness of telemedicine devices in patients with severe heart failure with an implanted cardiac resynchronization therapy system during two years of observation. Kardiol Pol. 2022; 80(1): 41–48.
  7. Mairesse GH, Braunschweig F, Klersy K, et al. Implementation and reimbursement of remote monitoring for cardiac implantable electronic devices in Europe: a survey from the health economics committee of the European Heart Rhythm Association. Europace. 2015; 17(5): 814–818.
  8. Papavasileiou LP, Forleo GB, Panattoni G, et al. Work burden with remote monitoring of implantable cardioverter defibrillator: is it time for reimbursement policies? J Cardiovasc Med (Hagerstown). 2013; 14(2): 114–119.
  9. O'Shea CJ, Middeldorp ME, Hendriks JM, et al. Remote Monitoring Alert Burden: An Analysis of Transmission in >26,000 Patients. JACC Clin Electrophysiol. 2021; 7(2): 226–234.
  10. Recommendation of the Agency for Health Technology Assessment and Tariff System (AOTMiT) no 101/2018 from 25 October 2018 entitled “Telemetric monitoring of patients with an implanted cardioversion-defibrillation system (ICD) or cardiac resynchronization therapy with defibrillation function (CRT-D)” as a guaranteed outpatient specialised care service. Available online: https: // (Access: December 14, 2021).
  11. Buchta P, Tajstra M, Kurek A, et al. The impact of remote monitoring of implanted cardioverter-defibrillator (ICD) and cardiac resynchronisation therapy device (CRT-D) patients on healthcare costs in the Silesian population: three-year follow-up. Kardiol Pol. 2017; 75(6): 573–580.
  12. Health Quality Ontario. Remote Monitoring of Implantable Cardioverter-Defibrillators, Cardiac Resynchronization Therapy and Permanent Pacemakers: A Health Technology Assessment. Ont Health Technol Assess Ser. 2018; 18(7): 1–199.


Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Sp. z o.o. VM Group Sp.k., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: